You are here: Home Why IMD3?

Why IMD3?

by Wittliff,James L. last modified Aug 03, 2009 11:13 AM

  • Newly revitalized and expanding Initiatives to Move Discoveries to Drugs and Diagnostics
  • Established collaborations of unconventional combinations, with more in progress
  • Winning concepts, new grants, patents and licensesLCM
  • Combinatorial chemistry; high throughput screening
  • Molecular modeling and drug design
  • Database development and mining
  • ab initio molecular structure for defined functions
  • Protein and steroid hormone mimics by design
  • Cell surface characteristics, trafficking and signaling
  • Sensitive receptor assays for assessing compound activities
  • Expertise with peptides, carbohydrates, nucleic acids, lipids, and natural products
  • Genomics, proteomics and metabolomics for assessing disease status and identifying molecular targets
  • Industrial collaborations and  internships
  • Unique IMD3 collection of compounds with diverse structures
  • University fellowships and summer scholars program for multidisciplinary training
  • IMD3 Symposium on contemporary topics
  • Graduate student partnering and development; Fall Fest, travel awards and presentations
  • Modern instrumentation for characterization and analysis

Current initiatives include establishing benchmarks for funding and publications, attracting additional industrial support, increasing patents and licensing opportunities, adding another endowed chair, designing a facility for a core synthesis and chemical collection storage and a chemoinformatics laboratory, and submitting a joint research proposal or training grant to a national funding agency.

Document Actions
Personal tools